Qube Research & Technologies Ltd
- SEC CIK
- 0001729829
- Latest filing
- Aug 14, 2026
GALT holding history
Galectin Therapeutics Inc in every 13F filed by Qube Research & Technologies Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GALT overviewAll 13F holders of GALTFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −126,439−100.0% | Sold out | Holders |
| Q1 2026 | 126,439 | $352.8K | <0.1% | +51,796+69.4% | Added | Holders |
| Q4 2025 | 74,643 | $310.5K | <0.1% | +13,776+22.6% | Added | Holders |
| Q3 2025 | 60,867 | $257.8K | <0.1% | +45,297+290.9% | Added | Holders |
| Q2 2025 | 15,570 | $32.9K | <0.1% | +391+2.6% | Added | Holders |
| Q1 2025 | 15,179 | $18.5K | <0.1% | +3,049+25.1% | Added | Holders |
| Q4 2024 | 12,130 | $15.6K | <0.1% | +12,130 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −69,045−100.0% | Sold out | Holders |
| Q1 2024 | 69,045 | $165.0K | <0.1% | −6,367−8.4% | Reduced | Holders |
| Q4 2023 | 75,412 | $125.2K | <0.1% | +71,790+1,982.1% | Added | Holders |
| Q3 2023 | 3,622 | $6.95K | <0.1% | +3,622 | New | Holders |